Face allotransplantation and burns: A review

Journal of Burn Care and Research

Volumn 33, Issue 5, 2012, Pages 561-576

  Arno, Anna ^a,b   Barret, J P ^a   Harrison, Rachael A ^b   Jeschke, Marc G ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADRENAL SUPPRESSION; ALLOTRANSPLANTATION; ANEMIA; ASEPTIC NECROSIS; BODY FAT DISTRIBUTION; BODY IMAGE; BURN; CATARACT; CHRONIC GRAFT REJECTION; COMPOSITE GRAFT; DIARRHEA; DRUG DOSE REDUCTION; FACIAL TRANSPLANTATION; FOLLOW UP; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOMAGNESEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LEUKOPENIA; NEPHROTOXICITY; NEUROTOXICITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PAIN; PATIENT COMPLIANCE; PEPTIC ULCER; PERIPHERAL EDEMA; PLASTIC SURGERY; REVIEW; SELF ESTEEM; SEPSIS; SIDE EFFECT; SKIN ATROPHY; SURGICAL TECHNIQUE; TREATMENT FAILURE;

BURNS; FACE; FACIAL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION CONTROL; POSTOPERATIVE COMPLICATIONS;

EID: 84866401515     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e318247eb06     Document Type: Review

References (105)

1. Lee WA, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991;87:401-11.
2. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg 1971;47:425-31.
3. Madani H, Hettiaratchy S, Clarke A, Butler PE. Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation. J Plast Reconstr Aesthet Surg 2008;61:245-9.
4. Petruzzo P, Kanitakis J, Badet L, et al. Long-term follow-up in composite tissue allotransplantation: In-depth study of five (hand and face) recipients. Am J Transplant 2001;11:808-16.
5. Hettiaratchy S, Randolph MA, Petite F, et al. Composite tissue allotransplantation: a new era in plastic surgery? Br J Plast Surg 2004;57:381-91.
6. Gilbert R. Transplant is successful with a cadaver forearm. Med Trib Med News 1964;5:20-2.
7. Brandacher G, Gorantla VS, Lee WP. Hand allotransplantation. Semin Plast Surg 2010;24:11-7.
8. Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007;357:2451-60.
9. Siemionow M, Bassiri Gharb B, Rampazzo A. The face as a sensory organ. Plast Reconstr Surg 2011;127:652-62.
10. Soni CV, Barker JH, Pushpakumar SB, et al. Psychosocial considerations in facial transplantation. Burns 2010;36: 959-64.
11. McIndoe AH. Total reconstruction of the burned face. The Bradshaw Lecture 1958. Br J Plast Surg 1983;36:410-20.
12. Latifoglu O, Ayhan S, Atabay K. Total face reconstruction: skin graft versus free flap. Plast Reconstr Surg 1999; 103:1076-8.
13. Angrigiani C, Grilli D. Total face reconstruction with one free flap. Plast Reconstr Surg 1997;99:1566-75.
14. Siemionow M, Unal S, Agaoglu G, Sari A. A cadaver study in preparation for facial allograft transplantation in humans: part I. What are alternative sources for total facial defect coverage? Plast Reconstr Surg 2006;117:864-72.
15. Pushpakumar SB, Barker JH, Soni CV, et al. Clinical considerations in face transplantation. Burns 2010;36:951-8.
16. Hui-Chou HG, Nam AJ, Rodriguez ED. Clinical facial composite tissue allotransplantation: a review of the first four global experiences and future implications. Plast Reconstr Surg 2010;125:538-46.
17. Devauchelle N, Badet L, Lengele B, et al. First human face allograft: early report. Lancet 2006;368:203-9.
18. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: a 2 year follow-up study. Lancet 2008;372:631-8.
19. Pomahac B, Nowinski D, Diaz-Siso JR, et al. Face transplantation. Curr Probl Surg 2011;48:293-357.
20. Gordon CR, Aver RK, Abouhassan W, Siemionow M. Cytomegalovirus and other infectious issues related to face transplantation: specific considerations, lessons learned and future recommendations. Plast Reconstr Surg 2011;127:1515-23.
21. Morris PJ, Bradley JA, Doyal L, et al. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation 2004;77:330-8.
22. Hettiaratchy S, Butler PE. Face transplantation: fantasy or the future? Lancet 2002;360:5-6.
23. Petit F, Paraskevas A, Minns AB, Lee WP, Lantieri LA. Face transplantation: where do we stand? Plast Reconstr Surg 2004;113:1429-33.
24. Siemionow M, Ozwen S, Demir Y. Prospects for facial allograft transplantation in humans. Plast Reconstr Surg 2004;113:1421-8.
25. Morris P, Bradley A, Doyal L, et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation 2007;83:109-28.
26. Schneeberger S, Landin L, Jableki J, et al. Achievements and challenges in composite tissue allotransplantation. Transplant Int 2011;24:760-9.
27. Sarwer DB, Bartlett SP, Whitaker LA, Paige KT, Pertschuk MJ, Wadden TA. Adult psychological functioning of individuals born with craniofacial anomalies. Plast Reconstr Surg 1999;103:412-8.
28. Klapheke MM, Marcell C, Taliaferro G, Creamer B. Psychiatric assessment of candidates for hand transplantation. Microsurgery 2000;20:453-7.
29. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2010;90:1590-4.
30. Whitaker IS, Duggan EM, Alloway RR, et al. Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons. J Plast Reconstr Aesthet Surg 2008;61:481-92.
31. Gorantla VS, Barker JH, Jones JW Jr, Prabhune K, Maldonado C, Granger DK. Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies. Microsurgery 2000;20:420-9.
32. Lanzetta M, Petruzzo P, Dubernard JM, et al. Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol 2007;18:1-6.
33. Cendales L, Hardy MA. Immunological considerations in composite tissue transplantation: overview. Microsurgery 2002;20:412-9.
34. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002;2:807-18.
35. Vicari-Christensen M, Repper S, Basile S, Young D. Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for education patients and promoting adherence. Prog Transplant 2009;19:277-84.
36. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK506 in humans. Transplant Proc 1999;264:63-7.
37. Sratta RJ. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney recipients: a multicenter report. The FK/MMF Multi-Center Study Group. Transplant Proc 1997;29:654-5.
38. Clavijo-Alvarez JA, Hamad GG, Taieb A, Lee WP. Pharmacologic approaches to composite tissue allograft. J Hand Surg 2007;32:104-18.
39. Ferrer IR, Araki R, Ford ML. Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant 2011;11:654-9.
40. McKane W, Kanganas C, Preston R, et al. Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil. Transplant Proc 2001;33:1224-5.
41. Landin L, Cavadas PC, Rodriguez-Perez JC, et al. Improvement in renal function after late conversion of sirolimus-based immunosuppression in composite tissue allotransplantation. Transplantation 2010;90:691-2.
42. Nevins TE, Matas AJ. Medication noncompliance: another iceberg's tip. Transplantation 2004;77:776-8.
43. Baumeister S, Kleist C, Dohler B, et al. Risk of allogeneic hand transplantation. Microsurgery 2004;24:98-103.
44. Golshayan D, Pascual M. Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. Drugs 2008;68:2113-30.
45. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001;14:417-24.
46. Ramsamooj R, Llull R, Black KS, Hewitt CW. Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 1999;104:1365-71.
47. Ciancio G, Millar J, Garcia-Morales RO, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant recipients. Transplantation 2001;71:827-35.
48. Hivelin M, Siemionow M, Grimbert P, Lantieri L. Extracorporeal photopheresis: from solid organs to face transplantation. Transpl Immunol 2009;21:117-28.
49. Kuo YR, Goto S, Shih HS, et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 2009;87:1769-77.
50. Popp FC, Renner P, Eggenhofer E, et al. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl 2009;15:1192-98.
51. Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, Ildstad ST. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery 2000;20:441-7.
52. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 2010;6:577-83.
53. Siemionow MZ, Kulahci Y, Bozkurt M. Composite tissue allotransplantation. Plast Reconstr Surg 2009;124:e327-39.
54. Schneeberger S, Lucchina S, Lanzetta M, et al. Cytomegalovirus-related complications in human hand transplantation. Transplantation 2005;80:441-7.
55. Lautenschlager I. CMV infection, diagnosis and antiviral strategies after liver transplantation. Transpl Int 2009;22:1031-40.
56. Gordon CR, Siemionow M, Papay F, et al. The world's experience with facial transplantation: what have we learned thus far? Ann Plast Surg 2009;63:572-8.
57. Luan FL, Stuckey LJ, Park JM, Kaul D, Cibrik D, Ojo A. Six month prophylaxis is cost-effective in transplant patients at high risk of cytomegalovirus infection. J Am Soc Nephrol 2009;20:2449-58.
58. Danzinger-Isakov L, Kumar D. AST infectious diseases community of practice. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009;9:S258-62.
59. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003;37:221-9.
60. Okie S. Brave New face. N Engl J Med 2006;354:889-94.
61. Siemionow MZ, Papay F, Alam D, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009;374:203-9.
62. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1 year follow-up study. Lancet 2008;372:639-45.
63. Brill SE, Clarke A, Veale DM, Butler PE. Psychological management and body image issues in facial transplantation. Body Image 2006;3:1-15.
64. O'Carroll R, Couston M, Cossar J, Masterton G, Hayes PC. Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transpl 2003;9:712-20.
65. Wiggins O, Barker J. Patient selection for facial transplantation III: ethical considerations. Int J Surg 2004;2:118-9.
66. Lantieri L, Hivelin M, Audard V, et al. Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes. Am J Transplant 2011;11:367-78.
67. Barker JH, Brown CS, Cunningham M, et al. Ethical considerations in human facial tissue allotransplantation. Ann Plast Surg 2008;60:103-9.
68. Wallace CG, Wei FC. The current status, evolution and future of facial reconstruction. Chang Gung Med J 2008;31:441-7.
69. Tanner PB, Mobley SR. External auricular and facial prosthetics: a collaborative effort of the reconstructive surgeon and anaplastologist. Facial Plast Surg Clin North Am 2006;14:137-45.
70. Nerem RM. Tissue engineering: the hope, the hype, and the future. Tissue Eng 2006;12:1143-50.
71. Neumeister MW, Wu T, Chambers C. Vascularized tissue-engineered ears. Plast Reconstr Surg 2006;117:116-22.
72. Barret JP, Gavalda J, Bueno J, et al. Full face transplant: the first case report. Ann Surg 2011;254:252-6.
73. Bueno J, Barret JP, Serracanta J, et al. Logistics and strategy of multiorgan procurement involving total face allograft. Am J Transplant 2011;11:1091-7.
74. Yi C, Guo S. Facial transplantation: lessons so far. Lancet 2009;374:177-8.
75. Pomahac B, Pribaz J, Eriksson E, et al. Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant 2011;11:386-93.
76. Pomahac B, Lengele B, Ridgway EB, et al. Vascular considerations in composite midfacial allotransplantation. Plast Reconstr Surg 2010;125:517-22.
77. Ryan CM, Schoenfeld DA, Thorpe WE, Sheridan RL, Cassem EH, Tompkins RG. Objective estimates of the probability of death from burn injuries. N Engl J Med 1998;338:362-6.
78. Dissanaike S, Rahimi M. Epidemiology of burn injuries: highlighting cultural and sociodemographic aspects. Int Rev Psychiatry 2009;21:505-11.
79. Atiyeh BS, Costagliola M, Hayek SN. Burn prevention mechanisms and outcomes: pitfalls, failures and successes. Burns 2009;35:181-93.
80. Brussselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity and mortality. Crit Care 2010;14:R188.
81. Clarke A, Butler PE. Facial transplantation: adding to the reconstructive options after severe facial injury and disease. Expert Opin Biol Ther 2005;5:1539-46.
82. Furr LA, Wiggins O, Cunningham M, et al. Psychosocial implications of disfigurement and the future of human face transplantation. Plast Reconstr Surg 2007;120:559-65.
83. MacGregor FC. Facial disfigurement: problems and management of social interaction and implications for mental health. Aesthetic Plast Surg 1990;14:249-57.
84. Siemionow M, Gatherwright J, Diohan R, Papay F. Cost analysis of conventional facial reconstruction procedures followed by face transplantation. Am J Transplant 2011;11:379-85.
85. Washington KM, Zanoun RR, Cadogan KA, Afrooz PN, Losee JE. Composite tissue allotransplantation for the reconstruction of congenital craniofacial defects. Transplant Proc 2009;41:523-7.
86. Kung TA, Gosain AK. Pediatric facial burns. J Craniofac Surg 2008;19:951-9.
87. LaRosa C, Baluarte HJ, Meyers KE. Outcomes in pediatric solid-organ transplantation. Pediatr Transplant 2011; 15:128-41.
88. McGrouther DA. Facial disfigurement. BMJ 1997;314:991.
89. Partridge J. Changing faces: the challenge of facial disfigurement. London, UK: Penguin Books; 1990.
90. Schilder P. The image and appearance of the human body. London, England: Kegan Paul, Trench, Trubner & Co., Ltd.; 1935.
91. Slade PD. What is body image? Behave Res Ther 1994; 32:497-502.
92. Sainsbury DC. Body image and facial burns. Adv Skin Wound Care 2009;22:39-44.
93. Price B. Body image: nursing concepts and care. New York, NY: Prentice Hall; 1990.
94. Rumsey Y, Harcourt D. Body image and disfigurement: issues and interventions. Body Image 2004;1:83-97.
95. Noyes R Jr, Frye SJ, Slymen DJ, Canter A. Stressful life events and burn injuries. J Trauma 1979;19:141-4.
96. Bradbury E. Understanding the problems. In: Lansdown R, Rumsey N, Bradbury E, editors. Visibly different: coping with disfigurement. London, England: Butterworth Heineman; 1999.
97. Kubler-Ross E. On death and dying. London, England: Tavistock Publications; 1969.
98. Levine E, Degutis L, Pruzinsky T, Shin J, Persing JA. Quality of life and facial trauma: psychological and body image effects. Ann Plast Surg 2005;54:502-10.
99. Newell R. Altered body image: a fear-avoidance model of psycho-social difficulties following disfigurement. J Adv Nurs 1999;30:1230-8.
100. Rumsey N, Clarke A, Musa M. Altered body image: the psychosocial needs of patients. Br J Community Nurs 2002;7:563-6.
101. Thompson A, Kent G. Adjusting to disfigurement: processes involved in dealing with being visible different. Clin Psychol Rev 2001;21:663-82.
102. Cobb S. Presidential Address-1976. Social support as a moderator of life stress. Psychosom Med 1976;38:300-14.
103. Sinno HH, Thibaudeau S, Duggal A, Lessard L. Utility scores for facial disfigurement requiring facial transplantation (outcomes article). Plast Reconstr Surg 2010;126:443-9.
104. Barker JH, Vossen M, Banis JC Jr. The technical, immunological and ethical feasibility of face transplantation. Int J Surg 2004;11:RA41-7.
105. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008;8: 1396-400.